SpartanNash Company (SPTN) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved third consecutive year of record adjusted EBITDA at $258.5 million, with margin-enhancing programs delivered ahead of schedule and Q4 adjusted EBITDA up 9% year-over-year.
Fiscal 2024 net sales reached $9.55 billion, with Q4 net sales up 0.73% to $2.26 billion; returned to top-line growth in Q4.
Cash from operating activities increased over 130% year-over-year, totaling $205.9 million.
Completed three acquisitions in 2024, with integration underway and acquired stores outperforming forecasts.
Focused on organic and inorganic growth, including expansion in ethnic and convenience store segments and transformational initiatives.
Financial highlights
Full-year net sales declined less than 2% to $9.55 billion, but Q4 sales returned to growth.
Gross profit for Q4 increased to $365 million (16.1% of net sales), up from $339 million (15.1%) year-over-year.
Q4 net loss of $35.1 million due to a $45.7 million Retail goodwill impairment; adjusted Q4 net earnings rose to $14.4 million ($0.42 per share).
Adjusted EPS for FY24 was $2.03, with significant adjustments for LIFO expense, restructuring, and integration costs.
Net long-term debt at year-end was $732.2 million, up from $579.5 million the previous year.
Outlook and guidance
Fiscal 2025 net sales expected at $9.8–$10 billion (midpoint 3.7% growth); adjusted EBITDA guidance of $263–$278 million (midpoint 4.6% growth).
Adjusted EPS projected at $1.60–$1.85 per diluted share; CapEx planned at $150–$165 million.
Guidance includes impact of tuck-in acquisitions, transformational programs, and an extra week in fiscal 2025.
Food inflation expected at 1% for the year; organic growth anticipated to be flat amid modest inflation.
53rd week to add $0.2 billion in sales, $4 million adjusted EBITDA, and $0.06 adjusted EPS.
Latest events from SpartanNash Company
- Net sales rose 1.8% to $2.27B, with Retail growth and a pending $1.77B merger with C&S.SPTN
Q2 2025 - Q3 sales dipped 0.6% as cash flow rose and acquisitions support future EBITDA growth.SPTN
Q3 2024 - Q2 net sales declined 3.5%, adjusted EPS was $0.59, and 2024 guidance was reaffirmed.SPTN
Q2 2024 - Sales up 3.7% to $2.91B, record adjusted EBITDA, but net earnings fell on higher costs.SPTN
Q1 2025